Skip to main content
Clinical Trials/NCT01716078
NCT01716078WithdrawnNot Applicable

The Effect of Brachial Plexus Nerve Block on Distal Peripheral Nerve Conduction

Defense and Veterans Center for Integrative Pain Management1 site in 1 countryStarted: November 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Sponsor
Locations
1
Primary Endpoint
Compund Muscle Action Potential (CMAP) amplitude

Study Overview

Brief Summary

The purpose of this study is to determine the conducting ability of distal extremity nerves after a supraclavicular brachial plexus nerve block (with local anesthetic) has been placed at a more proximal location in the upper extremity.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Male and female military health care beneficiaries 18 years and older, capable of providing informed consent indicating awareness of the investigational nature of the study, in keeping with institutional policy
  • Written informed consent must be obtained from each patient prior to entering the study
  • Patients must be willing to have a regional anesthetic nerve block placed prior to their scheduled procedure
  • Patients must be willing to have neurodiagnostic tests performed prior to placement and after placement of the regional anesthesia nerve block

Exclusion Criteria

  • Refusal to have a brachial plexus nerve block placed
  • Refusal to have serial nerve conduction studies performed
  • Contraindication for a regional anesthesia nerve block (allergy to local anesthetic, infection at site of injection, elevated coagulation time)
  • Presence of conditions affecting the hand or arm (e.g., injury, infection) that might preclude the performance of nerve conduction studies
  • Presence of known major abnormalities of nerve conduction, e.g., absent median sensory potential in a patient scheduled for carpal tunnel release
  • Presence of conditions affecting the contralateral hand or arm (e.g., injury, infection) that might preclude the performance of sensory and motor studies to test block or absence of a contralateral upper extremity

Outcomes

Primary Outcomes

Compund Muscle Action Potential (CMAP) amplitude

Time Frame: 1 day

measured for motor studies from baseline to peak in mV

Secondary Outcomes

  • Distal Latency(1 day)
  • Peak Latency(1 day)
  • Onset Latency(1 day)

Investigators

Sponsor
Defense and Veterans Center for Integrative Pain Management
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials